Bolt Biotherapeutics Inc. (BOLT)
Market Open
15 Jun, 14:39
NASDAQ (CM) NASDAQ (CM) Primary $
4. 57
+0.01
+0.2193%
$
8.76M Market Cap
- P/E Ratio
- Div Yield
3,450 Volume
- Eps
$ 4.56
Previous Close Analysts:
Want to track BOLT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bolt Biotherapeutics Inc. (BOLT) Statistics
Valuation metrics
Market Cap 8.76M
Enterprise value 19.46M
Trailing P/E (ttm) -0.29
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 1.35
Price/Book (mrq) 0.43
Enterprise Value/Revenue 2.99
Enterprise Value/EBITDA -0.68
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 34.07K
Average volume (90 days) 26.46K
Price summary
52-Week low 3.91
52-Week high 7.2
Beta -
50-Day moving average 4.77
200-Day moving average 5.1
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 9 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.55%
Operating margin -4.63%
Operational effectiveness
Return on assets -0.62%
Return on equity -1.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.48
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -15.82
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 12.24
Total debt (mrq) -
Total Debt/Equity (mrq) 1.13
Current ratio (mrq) 3.51%
Book value per share (mrq) 10.6
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
